Bluejay Diagnostics, Inc. SEC filings BJDX
Bluejay Diagnostics, Inc. has 249 filings in SEC EDGAR's recent list, going back to Apr 19, 2017. Its latest annual report, Form 10-K, was filed on Mar 6, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (change to shareholder rights, bylaw or fiscal year change, shareholder vote results, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results, Other events
|
Nov 4, 2026 | Oct 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 13, 2026 | Oct 13, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 6, 2026 | Oct 6, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Sep 8, 2026 | Sep 1, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 13, 2026 | Aug 13, 2026 |
| S-8 | Employee stock plan registration | Aug 12, 2026 | — |
| 10-Q | Quarterly report | Aug 12, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 22, 2026 | Jul 21, 2026 |
| EFFECT | Filing | Jun 26, 2026 | — |
| 424B3 | Prospectus | Jun 26, 2026 | — |
| S-3 | Shelf registration | Jun 17, 2026 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 9, 2026 | Jun 9, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jun 8, 2026 | Jun 2, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jun 2, 2026 | May 27, 2026 |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| DEF 14A | Proxy statement | Apr 30, 2026 | Jun 9, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 20, 2026 | Apr 20, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 7, 2026 | Apr 7, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Mar 17, 2026 | Mar 14, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 16, 2026 | Mar 13, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 12, 2026 | Mar 12, 2026 |
| 10-K | Annual report | Mar 6, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 6, 2026 | Mar 6, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 20, 2026 | Feb 20, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 18, 2026 | Feb 17, 2026 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results, Other events
|
Jan 30, 2026 | Jan 27, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 30, 2025 | Dec 29, 2025 |
| EFFECT | Filing | Nov 26, 2025 | — |
| 424B3 | Prospectus | Nov 26, 2025 | — |
| CORRESP | Letter to the SEC | Nov 25, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 10, 2025 | Nov 10, 2025 |
| 10-Q | Quarterly report | Nov 7, 2025 | Sep 30, 2025 |
| S-3 | Shelf registration | Oct 23, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Oct 14, 2025 | Oct 9, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Oct 9, 2025 | Oct 3, 2025 |
| 8-K |
Current report
Other events
|
Aug 15, 2025 | Aug 15, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 11, 2025 | Aug 7, 2025 |
| 10-Q | Quarterly report | Aug 7, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Material agreement
|
Jul 28, 2025 | Jul 23, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 20, 2025 | Jun 18, 2025 |
| DEFA14A | Additional proxy material | Jun 4, 2025 | — |
| 8-K |
Current report
Other events
|
Jun 4, 2025 | Jun 3, 2025 |
| 8-K |
Current report
Officer or director change
|
May 28, 2025 | May 28, 2025 |
| DEF 14A | Proxy statement | May 16, 2025 | Jun 18, 2025 |
| 10-Q | Quarterly report | May 13, 2025 | Mar 31, 2025 |
| 424B3 | Prospectus | May 8, 2025 | — |
| EFFECT | Filing | May 7, 2025 | — |
| PRE 14A | Preliminary proxy statement | May 6, 2025 | May 5, 2025 |
| CORRESP | Letter to the SEC | May 5, 2025 | — |
| UPLOAD | Letter from the SEC | May 2, 2025 | — |
| S-3 | Shelf registration | Apr 29, 2025 | — |
| 10-K/A | Amended annual report | Apr 29, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Apr 9, 2025 | Apr 7, 2025 |
| 10-K | Annual report | Mar 31, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Other events
|
Dec 4, 2024 | Dec 3, 2024 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results, Other events
|
Nov 18, 2024 | Nov 15, 2024 |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Oct 24, 2024 | Oct 23, 2024 |
| DEFA14A | Additional proxy material | Oct 16, 2024 | — |
| 8-K |
Current report
Bylaw or fiscal year change
|
Oct 16, 2024 | Oct 16, 2024 |
| DEF 14A | Proxy statement | Sep 10, 2024 | Oct 23, 2024 |
| PRE 14A | Preliminary proxy statement | Aug 30, 2024 | Aug 30, 2024 |
| 8-K |
Current report
Listing notice, Bylaw or fiscal year change, Other events
|
Aug 28, 2024 | Aug 23, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Aug 21, 2024 | Aug 21, 2024 |
| 10-Q | Quarterly report | Aug 14, 2024 | Jun 30, 2024 |
| DEF 14A | Proxy statement | Jul 16, 2024 | Aug 21, 2024 |
| PRE 14A | Preliminary proxy statement | Jul 5, 2024 | Jul 5, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Jun 28, 2024 | Jun 27, 2024 |
| 424B1 | Prospectus | Jun 28, 2024 | — |
| EFFECT | Filing | Jun 26, 2024 | — |
| CORRESP | Letter to the SEC | Jun 25, 2024 | — |
| CORRESP | Letter to the SEC | Jun 25, 2024 | — |
| S-1/A | Amended registration statement | Jun 24, 2024 | — |
| UPLOAD | Letter from the SEC | Jun 24, 2024 | — |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results, Other events
|
Jun 20, 2024 | Jun 17, 2024 |
| S-1 | Registration statement | Jun 17, 2024 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
May 31, 2024 | May 31, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
May 16, 2024 | May 14, 2024 |
| 10-Q | Quarterly report | May 15, 2024 | Mar 31, 2024 |
| DEF 14A | Proxy statement | Apr 15, 2024 | May 14, 2024 |
| PRE 14A | Preliminary proxy statement | Apr 5, 2024 | Apr 5, 2024 |
| 8-K |
Current report
Officer or director change, Other events
|
Apr 2, 2024 | Mar 29, 2024 |
| 10-K | Annual report | Mar 28, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Listing notice
|
Mar 4, 2024 | Feb 28, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Jan 2, 2024 | Dec 27, 2023 |
| 424B4 | Prospectus | Dec 29, 2023 | — |
| EFFECT | Filing | Dec 27, 2023 | — |
| S-1/A | Amended registration statement | Dec 27, 2023 | — |
| 8-K |
Current report
Other events
|
Dec 27, 2023 | Dec 27, 2023 |
| CORRESP | Letter to the SEC | Dec 22, 2023 | — |
| CORRESP | Letter to the SEC | Dec 22, 2023 | — |
| S-1/A | Amended registration statement | Dec 21, 2023 | — |
| UPLOAD | Letter from the SEC | Nov 30, 2023 | — |
| S-1 | Registration statement | Nov 21, 2023 | — |
| 10-Q | Quarterly report | Nov 9, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2023 | Nov 9, 2023 |
| 8-K |
Current report
Material agreement
|
Oct 26, 2023 | Oct 23, 2023 |
| 8-K |
Current report
Officer or director change
|
Oct 16, 2023 | Oct 14, 2023 |
| 8-K |
Current report
Officer or director change
|
Oct 2, 2023 | Sep 26, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Aug 28, 2023 | Aug 24, 2023 |
| 424B5 | Prospectus supplement | Aug 28, 2023 | — |
| 8-K |
Current report
Results of operations
|
Aug 16, 2023 | Aug 16, 2023 |
| 10-Q | Quarterly report | Aug 14, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Other events
|
Aug 10, 2023 | Aug 8, 2023 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results, Other events
|
Jul 21, 2023 | Jul 21, 2023 |
| EFFECT | Filing | Jun 20, 2023 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 20, 2023 | Jun 14, 2023 |
| CORRESP | Letter to the SEC | Jun 15, 2023 | — |
| UPLOAD | Letter from the SEC | Jun 15, 2023 | — |
| S-3 | Shelf registration | Jun 5, 2023 | — |
| 8-K |
Current report
Other events
|
May 19, 2023 | May 19, 2023 |
| DEF 14A | Proxy statement | May 18, 2023 | Jun 14, 2023 |
| 10-Q | Quarterly report | May 11, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 10, 2023 | May 10, 2023 |
| PRE 14A | Preliminary proxy statement | May 8, 2023 | May 5, 2023 |
| 10-K/A | Amended annual report | May 1, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Listing notice
|
Apr 27, 2023 | Apr 25, 2023 |
| 10-K | Annual report | Mar 20, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 20, 2023 | Mar 20, 2023 |
| 8-K |
Current report
Officer or director change
|
Jan 27, 2023 | Jan 27, 2023 |
| 10-Q | Quarterly report | Nov 9, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2022 | Nov 8, 2022 |
| 8-K |
Current report
Listing notice
|
Oct 28, 2022 | Oct 25, 2022 |
| 10-Q | Quarterly report | Aug 10, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Jul 26, 2022 | Jul 26, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 15, 2022 | Jun 9, 2022 |
| DEF 14A | Proxy statement | May 13, 2022 | Jun 9, 2022 |
| 10-Q | Quarterly report | May 9, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
Apr 20, 2022 | Apr 20, 2022 |
| S-8 | Employee stock plan registration | Apr 19, 2022 | — |
| 8-K |
Current report
Officer or director change
|
Apr 1, 2022 | Mar 30, 2022 |
| 8-K |
Current report
Officer or director change
|
Mar 28, 2022 | Mar 23, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 10, 2022 | Mar 10, 2022 |
| 10-K | Annual report | Mar 10, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 31, 2022 | Jan 31, 2022 |
| 8-K |
Current report
Results of operations
|
Dec 16, 2021 | Dec 16, 2021 |
| 10-Q | Quarterly report | Dec 16, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Material agreement, Officer or director change, Other events
|
Nov 16, 2021 | Nov 10, 2021 |
| 424B4 | Prospectus | Nov 12, 2021 | — |
| EFFECT | Filing | Nov 9, 2021 | — |
| S-1MEF | Filing | Nov 9, 2021 | — |
| CORRESP | Letter to the SEC | Nov 5, 2021 | — |
| CERT | Filing | Nov 5, 2021 | — |
| CORRESP | Letter to the SEC | Nov 5, 2021 | — |
| 8-A12B | For registration of certain classes | Nov 5, 2021 | — |
| S-1/A | Amended registration statement | Nov 3, 2021 | — |
| FWP | Free writing prospectus | Oct 27, 2021 | — |
| CORRESP | Letter to the SEC | Oct 25, 2021 | — |
| S-1/A | Amended registration statement | Oct 25, 2021 | — |
| UPLOAD | Letter from the SEC | Oct 15, 2021 | — |
| CORRESP | Letter to the SEC | Oct 4, 2021 | — |
| S-1 | Registration statement | Oct 4, 2021 | — |
| UPLOAD | Letter from the SEC | Sep 24, 2021 | — |
| DRSLTR | Filing | Sep 8, 2021 | — |
| DRS/A | Filing | Sep 8, 2021 | — |
| UPLOAD | Letter from the SEC | Aug 20, 2021 | — |
| DRS | Filing | Jul 22, 2021 | — |
| D | Filing | Jun 29, 2021 | — |
| D | Filing | Dec 10, 2020 | — |
| D | Filing | Oct 30, 2020 | — |
| D | Filing | Apr 23, 2019 | — |
| D | Filing | Apr 19, 2017 | — |
Showing 163 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- BJDX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Acton, MA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1704287
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.